RAINBOW1,462.00

Rainbow Childrens Medicare Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAPOLLOHOSPFORTISKIMSPOLYMEDPFIZERONESOURCEJUBLPHARMAVIJAYAMcap ₹14,848 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,296.91,515.91,703.11,820.1
Other Income37.151.043.836.5
Total Income1,334.01,566.91,746.91,856.6
Expenses
+ Cost of Materials Consumed165.3194.9227.0244.1
+ Employee Benefit Expense176.2206.4233.5248.8
+ Finance Costs59.172.577.680.7
+ Depreciation & Amortisation112.1138.4150.6158.6
+ Other Expenses526.6624.7698.4752.1
Total Expenses1,039.21,236.91,387.11,484.3
EBITDA428.9489.9544.2575.2
EBIT316.8351.4393.6416.6
Profit
PBT before Exceptional Items294.8330.0359.8372.3
+ Exceptional Items0.00.0-1.5-1.5
Pretax Income294.8330.0358.2370.8
+ Current Tax77.089.396.1101.3
+ Deferred Tax-0.5-3.5-19.4-20.8
Tax Expense76.585.876.780.5
Net Income218.3244.2281.5290.3
+ Net Income — Continuing Ops218.3244.2281.5290.3
+ Other Comprehensive Income1.3-0.1-0.7-0.9
Total Comprehensive Income219.6244.2280.8289.4
Net Income to Common217.0243.4278.3285.4
Minority Interest1.30.83.24.9
Per Share
Basic EPS21.3823.9727.4128.11
Diluted EPS21.3823.8427.4128.11
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.1-0.7-0.9
+ Items NOT to be Reclassified to P&L1.8-0.1-1.0-1.2
+ Tax on Items NOT to be Reclassified-0.0-0.2-0.3
+ Tax on Items NOT to be Reclassified — alt tag0.4
Comprehensive Income — Owners of Parent218.3243.3-0.774.4
Comprehensive Income — Non-controlling Interests1.30.8-0.00.4
Per Share — as-filed variants
Basic EPS — Continuing Operations21.3823.9727.4128.11
Diluted EPS — Continuing Operations21.3823.8427.4128.11
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,131.61,320.91,476.01,576.1
Gross Margin %87.2687.1486.6786.59
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)294.8330.0359.8372.3
− Exceptional Items (reconciliation)0.00.0-1.5-1.5
Net Income Adj (tax-effected)218.3244.2282.8291.5
EPS Adj21.3823.9727.5328.23
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital101.5101.6101.6101.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.